Disease/Infection News

RSS

Homeless patients with respiratory infections more likely to be treated with ventilators than non-homeless

Researchers from UCLA, Harvard Medical School, and the University of Tokyo found that during a recent six-year period, homeless people in New York state were more likely to hospitalized and treated with mechanical ventilators for respiratory infections than people who are not homeless.

22 Jun 2020

Study looks at how loneliness, perceived support has changed in response to COVID-19

Social distancing during the COVID-19 pandemic has not led to an overall increase in loneliness among Americans.

22 Jun 2020

Researchers provide evidence-based review on COVID-19 respiratory transmission

In a new article, scientists provide an exhaustive, evidence-based review of how COVID-19 droplets from infected patients spread through the air and describe how health care professionals can protect themselves.

22 Jun 2020

The role of brain cells in spreading HIV

Dr. Lena Al-Harthi speaks to News-Medical about her research into HIV treatment and the role of brain cells in spreading the HIV virus.

22 Jun 2020

Easy to say ‘get tested.’ Harder to do. Here’s how.

Will Bondurant decided to get tested for COVID-19 after attending three racial justice demonstrations over a five-day period in San Francisco, where he lives.

22 Jun 2020

Researchers explore notions of animality, illness and humanity

When it became apparent in early 2020 just how serious the COVID-19-pandemic was, prioritization among corona patients became an acute issue.

22 Jun 2020

As problems grow with Abbott’s fast COVID test, FDA standards are under fire

In mid-May, the Food and Drug Administration issued a rare public warning about an Abbott Laboratories COVID-19 test that for weeks had received high praise from the White House because of its speed: Test results could be wrong.

22 Jun 2020

How those with obsessive-compulsive disorder cope with added angst of COVID

Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.

22 Jun 2020

GlobalData: Further research into MIS-C could reveal how COVID-19 affects the immune system

Some children have developed a severe inflammatory response due to COVID-19 infection that appears similar to Kawasaki disease.

22 Jun 2020

Synthetic peptide could be an effective COVID-19 treatment and SARS-CoV-2 vaccine

Ligandal, one of the world’s leading genetic medicine companies, has modeled a synthetic peptide that could be an effective COVID-19 treatment and SARS-CoV-2 vaccine.

22 Jun 2020

How weather affects COVID-19 in India

With India now having endured six months of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there are now over 410,000 official cases in and more than 13,000 deaths recorded. Almost all these deaths have occurred in the last three months, April to June, with 100 deaths on April 4, 2020, increasing almost 16-fold by May 4, and 63-fold by June 4, 2020.

21 Jun 2020

SARS-CoV-2 saliva testing that omits the RNA extraction step

Even as the COVID-19 pandemic progresses throughout the world, the lack of consistent diagnostic testing has been a bugbear, preventing public health control of the spread of infection. A new study by researchers at the University of Illinois Urbana-Champaign and published on the preprint server bioRxiv in June 2020 reports a new testing method that uses saliva, does not require RNA extraction, and can be scaled up quickly and inexpensively.

21 Jun 2020

Massive proteomics investigation of COVID-19 infection

Researchers from Germany and Switzerland revealed functional effects of individual severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins on cellular level after infection. They placed the findings into the context of host signaling pathways in order to identify vulnerable parts of the virus amenable to treatment. The study is currently available on the bioRxiv preprint server.

21 Jun 2020

A highly sensitive and specific antibody test for COVID-19

A new proof-of-concept study by UK researchers, currently available on the medRxiv* preprint server, describes the development of an enzyme-linked immunosorbent assay that can be used when lower levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific-antibodies are present in serum and saliva samples.

21 Jun 2020

Research explores the biophysical behavior of SARS-CoV-2 nucleocapsid protein

In a groundbreaking paper currently available on the bioRxiv* preprint server, the researchers from the Washington University School of Medicine and Stony Brook University showed how nucleocapsid protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is dynamic, disordered and phase separates with RNA – informing, in turn, the discovery of drugs that disrupt viral packaging.

21 Jun 2020

Interesting study on which species may be infected by SARS-CoV-2

The team from the University of Cambridge and the Pirbright Institute found that the Spike protein on SARS-CoV-2 engages with the host cell receptor angiotensin-converting enzyme 2 (ACE2) across a wide range of animals, even though the Spike binding site shows a between-species variation in its amino acid composition.

21 Jun 2020

Promising candidate monoclonal antibodies show "exquisite potency" against SAR-CoV-2

Researchers at Columbia University, Dana-Farber Cancer Institute, and the National Institutes of Health have identified and characterized a range of monoclonal antibodies that potently neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

21 Jun 2020

Environmental conditions affect the stability of SARS-CoV-2, study finds

A new study led by Marshall University researcher M. Jeremiah Matson found that environmental conditions affect the stability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human nasal mucus and sputum.

21 Jun 2020

Infants tested positive for COVID-19 mostly have mild illness with fever

A report from Ann & Robert H. Lurie Children's Hospital of Chicago shows that infants under 90 days of age who tested positive for COVID-19 tend to be well, with little or no respiratory involvement. Fever was often found to be the primary or only symptom.

21 Jun 2020

Study finds widespread support for public health measures to limit spread of COVID-19

No mass gatherings. Stay-at-home orders. Nonessential business closures. Use of cloth face coverings. In April, these and other measures were adopted by states to try to mitigate the spread of COVID-19 in the U.S. and across the globe.

21 Jun 2020